ID   F262_HUMAN              Reviewed;         505 AA.
AC   O60825; O60824; Q5VVQ3; Q5VVQ4; Q9H3P1;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2001, sequence version 2.
DT   12-APR-2017, entry version 169.
DE   RecName: Full=6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2;
DE            Short=6PF-2-K/Fru-2,6-P2ase 2;
DE            Short=PFK/FBPase 2;
DE   AltName: Full=6PF-2-K/Fru-2,6-P2ase heart-type isozyme;
DE   Includes:
DE     RecName: Full=6-phosphofructo-2-kinase;
DE              EC=2.7.1.105;
DE   Includes:
DE     RecName: Full=Fructose-2,6-bisphosphatase;
DE              EC=3.1.3.46;
GN   Name=PFKFB2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=9652401; DOI=10.1046/j.1432-1327.1998.2540103.x;
RA   Heine-Suner D., Diaz-Guillen M.A., Lange A.J.,
RA   Rodriguez de Cordoba S.;
RT   "Sequence and structure of the human 6-phosphofructo-2-
RT   kinase/fructose-2,6-bisphosphatase heart isoform gene (PFKFB2).";
RL   Eur. J. Biochem. 254:103-110(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RX   PubMed=11374908; DOI=10.1006/geno.2001.6527;
RA   Soejima H., Kawamoto S., Akai J., Miyoshi O., Arai Y., Morohka T.,
RA   Matsuo S., Niikawa N., Kimura A., Okubo K., Mukai T.;
RT   "Isolation of novel heart-specific genes using the BodyMap database.";
RL   Genomics 74:115-120(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Matsutani A.;
RT   "Human insulinoma PFK2/F26DPase.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION AT SER-466, AND MUTAGENESIS OF SER-466.
RX   PubMed=11069105; DOI=10.1016/S0960-9822(00)00742-9;
RA   Marsin A.S., Bertrand L., Rider M.H., Deprez J., Beauloye C.,
RA   Vincent M.F., Van den Berghe G., Carling D., Hue L.;
RT   "Phosphorylation and activation of heart PFK-2 by AMPK has a role in
RT   the stimulation of glycolysis during ischaemia.";
RL   Curr. Biol. 10:1247-1255(2000).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466; THR-468; SER-483
RP   AND SER-493, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466; SER-483 AND
RP   SER-493, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-466; THR-475 AND
RP   SER-493, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Synthesis and degradation of fructose 2,6-bisphosphate.
CC   -!- CATALYTIC ACTIVITY: Beta-D-fructose 2,6-bisphosphate + H(2)O = D-
CC       fructose 6-phosphate + phosphate.
CC   -!- CATALYTIC ACTIVITY: ATP + D-fructose 6-phosphate = ADP + beta-D-
CC       fructose 2,6-bisphosphate.
CC   -!- ENZYME REGULATION: Phosphorylation results in the activation of
CC       the kinase activity.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60825-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60825-2; Sequence=VSP_004675;
CC   -!- TISSUE SPECIFICITY: Heart.
CC   -!- PTM: Phosphorylation by AMPK stimulates activity.
CC       {ECO:0000269|PubMed:11069105}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the
CC       phosphoglycerate mutase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ005577; CAA06605.1; -; Genomic_DNA.
DR   EMBL; AJ005578; CAA06606.1; -; mRNA.
DR   EMBL; AB044805; BAB19681.1; -; mRNA.
DR   EMBL; AF470623; AAL99386.1; -; mRNA.
DR   EMBL; AK292883; BAF85572.1; -; mRNA.
DR   EMBL; AL445493; CAH70777.1; -; Genomic_DNA.
DR   EMBL; AL445493; CAH70778.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93508.1; -; Genomic_DNA.
DR   EMBL; BC069350; AAH69350.1; -; mRNA.
DR   EMBL; BC069385; AAH69385.1; -; mRNA.
DR   EMBL; BC069583; AAH69583.1; -; mRNA.
DR   EMBL; BC069586; AAH69586.1; -; mRNA.
DR   EMBL; BC069600; AAH69600.1; -; mRNA.
DR   EMBL; BC075075; AAH75075.1; -; mRNA.
DR   EMBL; BC075076; AAH75076.1; -; mRNA.
DR   EMBL; BC112103; AAI12104.1; -; mRNA.
DR   EMBL; BC112105; AAI12106.1; -; mRNA.
DR   CCDS; CCDS31003.1; -. [O60825-2]
DR   CCDS; CCDS31004.1; -. [O60825-1]
DR   RefSeq; NP_001018063.1; NM_001018053.1. [O60825-2]
DR   RefSeq; NP_006203.2; NM_006212.2. [O60825-1]
DR   UniGene; Hs.282702; -.
DR   PDB; 5HTK; X-ray; 2.01 A; A/B=1-505.
DR   PDBsum; 5HTK; -.
DR   ProteinModelPortal; O60825; -.
DR   SMR; O60825; -.
DR   BioGrid; 111229; 22.
DR   IntAct; O60825; 20.
DR   MINT; MINT-3000455; -.
DR   STRING; 9606.ENSP00000356047; -.
DR   BindingDB; O60825; -.
DR   ChEMBL; CHEMBL3421525; -.
DR   DEPOD; O60825; -.
DR   iPTMnet; O60825; -.
DR   PhosphoSitePlus; O60825; -.
DR   BioMuta; PFKFB2; -.
DR   EPD; O60825; -.
DR   MaxQB; O60825; -.
DR   PaxDb; O60825; -.
DR   PeptideAtlas; O60825; -.
DR   PRIDE; O60825; -.
DR   Ensembl; ENST00000367079; ENSP00000356046; ENSG00000123836. [O60825-2]
DR   Ensembl; ENST00000367080; ENSP00000356047; ENSG00000123836. [O60825-1]
DR   GeneID; 5208; -.
DR   KEGG; hsa:5208; -.
DR   UCSC; uc001hfg.4; human. [O60825-1]
DR   CTD; 5208; -.
DR   DisGeNET; 5208; -.
DR   GeneCards; PFKFB2; -.
DR   HGNC; HGNC:8873; PFKFB2.
DR   HPA; HPA049975; -.
DR   HPA; HPA063575; -.
DR   MIM; 171835; gene.
DR   neXtProt; NX_O60825; -.
DR   OpenTargets; ENSG00000123836; -.
DR   PharmGKB; PA33212; -.
DR   eggNOG; KOG0234; Eukaryota.
DR   eggNOG; COG0406; LUCA.
DR   GeneTree; ENSGT00390000018751; -.
DR   HOGENOM; HOG000181112; -.
DR   HOVERGEN; HBG005628; -.
DR   InParanoid; O60825; -.
DR   KO; K19029; -.
DR   OMA; DQNKFAY; -.
DR   OrthoDB; EOG091G0A43; -.
DR   PhylomeDB; O60825; -.
DR   TreeFam; TF313541; -.
DR   BioCyc; MetaCyc:HS04690-MONOMER; -.
DR   BRENDA; 2.7.1.105; 2681.
DR   BRENDA; 3.1.3.46; 2681.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   SABIO-RK; O60825; -.
DR   SIGNOR; O60825; -.
DR   ChiTaRS; PFKFB2; human.
DR   GeneWiki; PFKFB2; -.
DR   GenomeRNAi; 5208; -.
DR   PRO; PR:O60825; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000123836; -.
DR   CleanEx; HS_PFKFB2; -.
DR   ExpressionAtlas; O60825; baseline and differential.
DR   Genevisible; O60825; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0003873; F:6-phosphofructo-2-kinase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004331; F:fructose-2,6-bisphosphate 2-phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0006003; P:fructose 2,6-bisphosphate metabolic process; IEA:InterPro.
DR   GO; GO:0006000; P:fructose metabolic process; TAS:ProtInc.
DR   GO; GO:0006096; P:glycolytic process; IDA:UniProtKB.
DR   GO; GO:0006089; P:lactate metabolic process; IEA:Ensembl.
DR   GO; GO:0033133; P:positive regulation of glucokinase activity; IEA:Ensembl.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   CDD; cd07067; HP_PGM_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR003094; 6Pfruct_kin.
DR   InterPro; IPR013079; 6Phosfructo_kin.
DR   InterPro; IPR013078; His_Pase_superF_clade-1.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001345; PG/BPGM_mutase_AS.
DR   PANTHER; PTHR10606; PTHR10606; 1.
DR   Pfam; PF01591; 6PF2K; 1.
DR   Pfam; PF00300; His_Phos_1; 1.
DR   PRINTS; PR00991; 6PFRUCTKNASE.
DR   SMART; SM00855; PGAM; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00175; PG_MUTASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Hydrolase; Kinase; Multifunctional enzyme;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    505       6-phosphofructo-2-kinase/fructose-2,6-
FT                                bisphosphatase 2.
FT                                /FTId=PRO_0000179964.
FT   NP_BIND      45     53       ATP. {ECO:0000250|UniProtKB:Q16875}.
FT   NP_BIND     167    172       ATP. {ECO:0000250|UniProtKB:Q16875}.
FT   NP_BIND     348    351       ATP. {ECO:0000250|UniProtKB:P07953}.
FT   NP_BIND     392    396       ATP. {ECO:0000250|UniProtKB:P07953}.
FT   REGION        2    248       6-phosphofructo-2-kinase.
FT   REGION      249    505       Fructose-2,6-bisphosphatase.
FT   ACT_SITE    128    128       {ECO:0000255}.
FT   ACT_SITE    158    158       {ECO:0000255}.
FT   ACT_SITE    257    257       Tele-phosphohistidine intermediate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   ACT_SITE    326    326       Proton donor/acceptor.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING      78     78       Fructose 6-phosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     102    102       Fructose 6-phosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     130    130       Fructose 6-phosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     136    136       Fructose 6-phosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     172    172       Fructose 6-phosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     193    193       Fructose 6-phosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     197    197       Fructose 6-phosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     256    256       Fructose 2,6-bisphosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     263    263       Fructose 2,6-bisphosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     269    269       Fructose 2,6-bisphosphate; via amide
FT                                nitrogen. {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     337    337       Fructose 2,6-bisphosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     351    351       Fructose 2,6-bisphosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     355    355       Fructose 2,6-bisphosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     366    366       Fructose 2,6-bisphosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     392    392       Fructose 2,6-bisphosphate.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   BINDING     396    396       Fructose 2,6-bisphosphate.
FT                                {ECO:0000250|UniProtKB:P07953}.
FT   BINDING     428    428       ATP. {ECO:0000250|UniProtKB:Q16875}.
FT   SITE        256    256       Transition state stabilizer.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   SITE        263    263       Transition state stabilizer.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   SITE        391    391       Transition state stabilizer.
FT                                {ECO:0000250|UniProtKB:Q16875}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      29     29       Phosphoserine; by PKA. {ECO:0000250}.
FT   MOD_RES     466    466       Phosphoserine; by AMPK.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11069105}.
FT   MOD_RES     468    468       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     475    475       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     483    483       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     493    493       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     451    505       NNFPKNQTPVRMRRNSFTPLSSSNTIRRPRNYSVGSRPLKP
FT                                LSPLRAQDMQEGAD -> AAETTLAVRRRPSAASLMLPC
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:11374908,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_004675.
FT   MUTAGEN     466    466       S->E: Constitutively active mutant that
FT                                cannot be phosphorylated and further
FT                                activated by AMPK.
FT                                {ECO:0000269|PubMed:11069105}.
FT   CONFLICT     28     28       Missing (in Ref. 1; CAA06605).
FT                                {ECO:0000305}.
FT   CONFLICT    303    304       QL -> HV (in Ref. 1; CAA06606).
FT                                {ECO:0000305}.
FT   CONFLICT    372    372       R -> L (in Ref. 1; CAA06606).
FT                                {ECO:0000305}.
FT   CONFLICT    396    396       R -> H (in Ref. 1; CAA06606).
FT                                {ECO:0000305}.
FT   CONFLICT    406    406       G -> D (in Ref. 1; CAA06606).
FT                                {ECO:0000305}.
FT   CONFLICT    427    427       A -> T (in Ref. 1; CAA06606).
FT                                {ECO:0000305}.
FT   STRAND       39     44       {ECO:0000244|PDB:5HTK}.
FT   STRAND       47     50       {ECO:0000244|PDB:5HTK}.
FT   HELIX        51     64       {ECO:0000244|PDB:5HTK}.
FT   STRAND       69     73       {ECO:0000244|PDB:5HTK}.
FT   HELIX        74     82       {ECO:0000244|PDB:5HTK}.
FT   HELIX        88     91       {ECO:0000244|PDB:5HTK}.
FT   HELIX        96    119       {ECO:0000244|PDB:5HTK}.
FT   STRAND      123    129       {ECO:0000244|PDB:5HTK}.
FT   HELIX       134    147       {ECO:0000244|PDB:5HTK}.
FT   STRAND      150    157       {ECO:0000244|PDB:5HTK}.
FT   HELIX       161    174       {ECO:0000244|PDB:5HTK}.
FT   HELIX       186    200       {ECO:0000244|PDB:5HTK}.
FT   TURN        206    212       {ECO:0000244|PDB:5HTK}.
FT   STRAND      215    219       {ECO:0000244|PDB:5HTK}.
FT   TURN        220    223       {ECO:0000244|PDB:5HTK}.
FT   STRAND      224    228       {ECO:0000244|PDB:5HTK}.
FT   HELIX       233    242       {ECO:0000244|PDB:5HTK}.
FT   STRAND      252    256       {ECO:0000244|PDB:5HTK}.
FT   HELIX       261    265       {ECO:0000244|PDB:5HTK}.
FT   HELIX       276    292       {ECO:0000244|PDB:5HTK}.
FT   STRAND      298    301       {ECO:0000244|PDB:5HTK}.
FT   HELIX       305    312       {ECO:0000244|PDB:5HTK}.
FT   HELIX       322    324       {ECO:0000244|PDB:5HTK}.
FT   HELIX       330    332       {ECO:0000244|PDB:5HTK}.
FT   HELIX       337    343       {ECO:0000244|PDB:5HTK}.
FT   HELIX       345    353       {ECO:0000244|PDB:5HTK}.
FT   TURN        355    357       {ECO:0000244|PDB:5HTK}.
FT   HELIX       366    382       {ECO:0000244|PDB:5HTK}.
FT   STRAND      384    390       {ECO:0000244|PDB:5HTK}.
FT   HELIX       392    402       {ECO:0000244|PDB:5HTK}.
FT   TURN        407    409       {ECO:0000244|PDB:5HTK}.
FT   HELIX       410    412       {ECO:0000244|PDB:5HTK}.
FT   STRAND      419    426       {ECO:0000244|PDB:5HTK}.
FT   STRAND      429    436       {ECO:0000244|PDB:5HTK}.
SQ   SEQUENCE   505 AA;  58477 MW;  5CD6A933A7EBF604 CRC64;
     MSGASSSEQN NNSYETKTPN LRMSEKKCSW ASYMTNSPTL IVMIGLPARG KTYVSKKLTR
     YLNWIGVPTK VFNLGVYRRE AVKSYKSYDF FRHDNEEAMK IRKQCALVAL EDVKAYLTEE
     NGQIAVFDAT NTTRERRDMI LNFAEQNSFK VFFVESVCDD PDVIAANILE VKVSSPDYPE
     RNRENVMEDF LKRIECYKVT YRPLDPDNYD KDLSFIKVIN VGQRFLVNRV QDYIQSKIVY
     YLMNIHVQPR TIYLCRHGES EFNLLGKIGG DSGLSVRGKQ FAQALRKFLE EQEITDLKVW
     TSQLKRTIQT AESLGVPYEQ WKILNEIDAG VCEEMTYAEI EKRYPEEFAL RDQEKYLYRY
     PGGESYQDLV QRLEPVIMEL ERQGNVLVIS HQAVMRCLLA YFLDKGADEL PYLRCPLHTI
     FKLTPVAYGC KVETIKLNVE AVNTHRDKPT NNFPKNQTPV RMRRNSFTPL SSSNTIRRPR
     NYSVGSRPLK PLSPLRAQDM QEGAD
//
